Salivary gland tumors at in vivo proton MR spectroscopy
- PMID: 16244265
- DOI: 10.1148/radiol.2372041309
Salivary gland tumors at in vivo proton MR spectroscopy
Abstract
Purpose: To prospectively evaluate whether proton magnetic resonance (MR) spectroscopy can be used to characterize salivary gland tumors (SGTs).
Materials and methods: Ethics committee approval and informed consent were obtained. Hydrogen 1 ((1)H) MR spectroscopy was performed with echo times of 136 and 272 msec at 1.5 T in both SGTs and normal parotid glands. Spectra were analyzed in the time domain by using prior knowledge in the fitting procedure to obtain peak amplitudes of choline (Cho), creatine (Cr), and unsuppressed water. Mean Cho/Cr and Cho/water ratios for each subgroup of SGTs were obtained, and results were compared by using a nonparametric t test.
Results: Successful spectra were acquired in 56 patients (35 men, 21 women; mean age, 56 years) with a total of nine malignant tumors and 47 benign SGTs (24 Warthin tumors, 22 pleomorphic adenomas, one oncocytoma). At an echo time of 136 msec, Cho/Cr ratios were obtained in 26 (47%) of 55 spectra, with a mean value (+/- standard deviation) of 1.73 +/- 0.47, 5.49 +/- 1.86, 3.46 +/- 0.84, and 2.45 for malignant tumors, Warthin tumors, pleomorphic adenomas, and oncocytoma, respectively. Differences were significant between Warthin tumors and pleomorphic adenomas (P = .028) and between benign SGTs and malignant tumors (P < .001). At an echo time of 272 msec, Cho/Cr ratios were obtained in 16 (30%) of 53 spectra, with a mean value of 2.27 +/- 0.69, 6.92 +/- 1.47, and 3.67 +/- 1.23 for malignant tumors, Warthin tumors, and pleomorphic adenomas, respectively. Differences were also significant between Warthin tumors and pleomorphic adenomas (P = .041) and benign SGTs and malignant tumors (P = .004). There was a significant difference in mean Cho/water ratio for Warthin tumors versus pleomorphic adenomas at echo times of 136 msec (P = .003) and 272 msec (P = .002) but not for benign SGTs versus malignant tumors.
Conclusion: (1)H MR spectroscopy may be used to characterize SGTs, but a larger study is required to validate these initial results.
Similar articles
-
Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.Radiology. 2003 Feb;226(2):345-54. doi: 10.1148/radiol.2262011486. Radiology. 2003. PMID: 12563124
-
Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors.Radiology. 2012 Jun;263(3):770-7. doi: 10.1148/radiol.12111248. Epub 2012 Mar 23. Radiology. 2012. PMID: 22447854
-
Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors.Oral Oncol. 2007 Oct;43(9):940-7. doi: 10.1016/j.oraloncology.2006.11.009. Epub 2007 Jan 25. Oral Oncol. 2007. PMID: 17257881
-
Radiomics Analysis in Characterization of Salivary Gland Tumors on MRI: A Systematic Review.Cancers (Basel). 2023 Oct 10;15(20):4918. doi: 10.3390/cancers15204918. Cancers (Basel). 2023. PMID: 37894285 Free PMC article. Review.
-
Advanced magnetic resonance imaging findings in salivary gland tumors.World J Radiol. 2022 Aug 28;14(8):256-271. doi: 10.4329/wjr.v14.i8.256. World J Radiol. 2022. PMID: 36160835 Free PMC article. Review.
Cited by
-
Pictorial essay: Salivary gland imaging.Indian J Radiol Imaging. 2012 Oct;22(4):325-33. doi: 10.4103/0971-3026.111487. Indian J Radiol Imaging. 2012. PMID: 23833425 Free PMC article.
-
Contemporary management of tumors of the salivary glands.Curr Oncol Rep. 2007 Mar;9(2):134-8. doi: 10.1007/s11912-007-0011-6. Curr Oncol Rep. 2007. PMID: 17288880 Review.
-
MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.AJNR Am J Neuroradiol. 2011 Aug;32(7):1202-7. doi: 10.3174/ajnr.A2520. Epub 2011 Jun 30. AJNR Am J Neuroradiol. 2011. PMID: 21724574 Free PMC article.
-
Biologic imaging of head and neck cancer: the present and the future.AJNR Am J Neuroradiol. 2012 Apr;33(4):586-94. doi: 10.3174/ajnr.A2535. Epub 2011 Dec 22. AJNR Am J Neuroradiol. 2012. PMID: 22194364 Free PMC article. Review.
-
Closing the uncertainty gap in the diagnosis of parotid tumors.AJNR Am J Neuroradiol. 2009 Mar;30(3):442-3. doi: 10.3174/ajnr.A1423. Epub 2008 Dec 12. AJNR Am J Neuroradiol. 2009. PMID: 19074547 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical